During the past decade, Tulane/LSU Maternal/Child CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tulane/LSU Maternal/Child CRS" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 14 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Glaxo Wellcome" with 4 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Tulane/LSU Maternal/Child CRS" are "HIV Infections" (34 trials), "Pneumonia, Pneumocystis Carinii" (4 trials), "Pregnancy" (3 trials), "Cervix, Dysplasia" (2 trials) and "Cytomegalovirus Infections" (1 trials). Many other conditions were trialed in "Tulane/LSU Maternal/Child CRS" in a lesser frequency.

Most popular intervention types in "Tulane/LSU Maternal/Child CRS" are "Drug" (26 trials), "Biological" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (9 trials), "Didanosine" (5 trials), "Lamivudine" (5 trials), "Nelfinavir mesylate" (4 trials) and "Stavudine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Tulane/LSU Maternal/Child CRS" are 29 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Tulane/LSU Maternal/Child CRS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Tulane/LSU Maternal/Child CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tulane/LSU Maternal/Child CRS, 17 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".